A big congratulations to Heather Manley, Site Director at Clinvest, for co-authoring a new study that explores how non-traditional, community-embedded research sites, known as frontier sites, can help address the industry’s growing capacity challenges.
The research, conducted through the Site Enablement League (SEL) Task Force, shows that frontier sites offer meaningful opportunities to reach underserved populations and expand trial access. Survey findings point to clear benefits in participant diversity and community engagement, alongside operational and compliance challenges that require targeted support.
This work lays the foundation for developing a future industry playbook to successfully integrate frontier sites into clinical trial operations.
Read more about the findings in Contemporary Clinical Trials Communications.